Literature DB >> 2836312

Cytomegalovirus infection in HIV-1-infected individuals.

U Süttmann1, H Willers, R Gerdelmann, W Höpken, I Schedel, H Deicher.   

Abstract

Urinary excretion of Cytomegalovirus and the presence of serum antibodies against CMV were examined in 79 HIV-1-infected patients at different stages of the disease, as well as in 27 heterosexual and 52 male homosexual controls and correlated to clinical and laboratory results. HIV-1-infected and healthy individuals differed significantly with regard to cutaneous delayed type reactions, absolute numbers of CD4+ cells and CD4+/CD8+ ratios. IgG antibodies against CMV were found in 87% of homosexual and in 52% of heterosexual controls, and in all HIV-1-infected homosexuals. CMV excretion in the urine was exclusively found in HIV-1-infected individuals where the incidence correlated with the CDC-defined disease stage (stage II: 6%, stage III/IV A: 22%, stage IV B/C: 55%). HIV-1-infected patients excreting CMV in the urine also exhibited distinctly decreased numbers of CD4+ cells and significantly decreased CD4+/CD8+ ratios compared to those without CMV viruria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836312     DOI: 10.1007/BF01644316

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

2.  Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.

Authors:  R D Schrier; G P Rice; M B Oldstone
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

3.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

4.  Absence of detectable IgM antibody during cytomegalovirus disease in patients with AIDS.

Authors:  J Dylewski; S Chou; T C Merigan
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

5.  Excretion of cytomegalovirus in semen associated with HTLV-III seropositivity in asymptomatic homosexual men.

Authors:  C R Rinaldo; L A Kingsley; D W Lyter; A J Bodner; S H Weiss; W C Saxinger
Journal:  J Med Virol       Date:  1986-09       Impact factor: 2.327

6.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

Authors:  J M Lange; R A Coutinho; W J Krone; L F Verdonck; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

7.  Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.

Authors:  V S Kalyanaraman; C D Cabradilla; J P Getchell; R Narayanan; E H Braff; J C Chermann; F Barré-Sinoussi; L Montagnier; T J Spira; J Kaplan
Journal:  Science       Date:  1984-07-20       Impact factor: 47.728

Review 8.  Epidemiology of cytomegaloviral infections: recommendations for prevention and control.

Authors:  I M Onorato; D M Morens; W J Martone; S K Stansfield
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

9.  Prevalence of cytomegalovirus infection in homosexual men.

Authors:  W L Drew; L Mintz; R C Miner; M Sands; B Ketterer
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

10.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  2 in total

1.  Efficacy of intravenous immunoglobulins in patients with advanced HIV-1 infection. A randomized clinical study.

Authors:  U Brunkhorst; M Stürner; H Willers; H Deicher; I Schedel
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

2.  [Diagnosis and clinical aspects of gastrointestinal cytomegalovirus diseases in patients with human immunodeficiency virus 1 infection].

Authors:  M Schrappe-Bächer; H M Steffen; G Ollenschläger; B Salzberger; G Fätkenheuer; S Degenhardt; G R Krüger
Journal:  Klin Wochenschr       Date:  1989-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.